Role of tumor size in the pre-operative management of rectal cancer patients

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Zlobec, Inti ^a   Minoo, Parham ^b   Karamitopoulou, Eva ^c   Peros, George ^c   Patsouris, Efstratios S ^c   Lehmann, Frank ^d   Lugli, Alessandro ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTERNAL VALIDITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PROGNOSIS; RECTUM CANCER; REGRESSION ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SWITZERLAND; TUMOR VOLUME; UNIVERSITY HOSPITAL; EVALUATION; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RECTUM TUMOR; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77953405565     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-61     Document Type: Article

References (48)

1. Daniels IR, Fisher SE, Heald RJ, Moran BJ. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Colorectal Dis 2007, 9(4):290-301. 10.1111/j.1463-1318.2006.01116.x, 17432979.
2. O'Neil BH, Tepper JE. Current options for the management of rectal cancer. Curr Treat Options Oncol 2007, 8(5):331-338. 10.1007/s11864-007-0048-7, 18181024.
3. Glimelius B, Oliveira J. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008, 19(Suppl 2):ii31-32. 10.1093/annonc/mdn078, 18456759.
4. Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007, 2:CD002102.
5. Akasu T, Iinuma G, Takawa M, Yamamoto S, Muramatsu Y, Moriyama N. Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer. Ann Surg Oncol 2009, 16(10):2787-2794. 10.1245/s10434-009-0613-3, 19618244.
6. Badger SA, Devlin PB, Neilly PJ, Gilliland R. Preoperative staging of rectal carcinoma by endorectal ultrasound: is there a learning curve?. Int J Colorectal Dis 2007, 22(10):1261-1268. 10.1007/s00384-007-0273-3, 17294198.
7. Beer-Gabel M, Assouline Y, Zmora O, Venturero M, Bar-Meir S, Avidan B. A new rectal ultrasonographic method for the staging of rectal cancer. Dis Colon Rectum 2009, 52(8):1475-1480.
8. Brown G, Davies S, Williams GT, Bourne MW, Newcombe RG, Radcliffe AG, Blethyn J, Dallimore NS, Rees BI, Phillips CJ, Maughan TS. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging?. Br J Cancer 2004, 91(1):23-29. 10.1038/sj.bjc.6601871, 2364763, 15188013.
9. Landmann RG, Wong WD, Hoepfl J, Shia J, Guillem JG, Temple LK, Paty PB, Weiser MR. Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum 2007, 50(10):1520-1525. 10.1007/s10350-007-9019-0, 17674104.
10. Mathur P, Smith JJ, Ramsey C, Owen M, Thorpe A, Karim S, Burke C, Ramesh S, Dawson PM. Comparison of CT and MRI in the pre-operative staging of rectal adenocarcinoma and prediction of circumferential resection margin involvement by MRI. Colorectal Dis 2003, 5(5):396-401. 10.1046/j.1463-1318.2003.00537.x, 12925069.
11. Bartram C, Brown G. Endorectal ultrasound and magnetic resonance imaging in rectal cancer staging. Gastroenterol Clin North Am 2002, 31(3):827-839. 10.1016/S0889-8553(02)00027-4, 12481733.
12. Pijl ME, Chaoui AS, Wahl RL, van Oostayen JA. Radiology of colorectal cancer. Eur J Cancer 2002, 38(7):887-898. 10.1016/S0959-8049(02)00052-7, 11978513.
13. Zorcolo L, Fantola G, Cabras F, Marongiu L, D'Alia G, Casula G. Preoperative staging of patients with rectal tumors suitable for transanal endoscopic microsurgery (TEM): comparison of endorectal ultrasound and histopathologic findings. Surg Endosc 2009, 23(6):1384-1389. 10.1007/s00464-009-0349-y, 19263149.
14. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, von Meyenfeldt MF, Baeten CG, van Engelshoven JM. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001, 357(9255):497-504. 10.1016/S0140-6736(00)04040-X, 11229667.
15. Blomqvist L, Holm T, Rubio C, Hindmarsh T. Rectal tumours--MR imaging with endorectal and/or phased-array coils, and histopathological staging on giant sections. A comparative study. Acta Radiol 1997, 38(3):437-444.
16. Blomqvist L, Machado M, Rubio C, Gabrielsson N, Granqvist S, Goldman S, Holm T. Rectal tumour staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography. Eur Radiol 2000, 10(4):653-660. 10.1007/s003300050979, 10795550.
17. Brown G, Richards CJ, Newcombe RG, Dallimore NS, Radcliffe AG, Carey DP, Bourne MW, Williams GT. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999, 211(1):215-222.
18. Jao SY, Yang BY, Weng HH, Yeh CH, Lee LW. Evaluation of gadolinium-enhanced T1-weighted MRI in the preoperative assessment of local staging in rectal cancer. Colorectal Dis 2009,
19. Jhaveri KS, Sadaf A. Role of MRI for staging of rectal cancer. Expert Rev Anticancer Ther 2009, 9(4):469-481. 10.1586/era.09.13, 19374600.
20. Kuremsky JG, Tepper JE, McLeod HL. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2009, 74(3):673-688.
21. Kikuchi M, Mikami T, Sato T, Tokuyama W, Araki K, Watanabe M, Saigenji K, Okayasu I. High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction. Br J Cancer 2009, 101(1):116-123. 10.1038/sj.bjc.6605105, 19491899.
22. Negri FV, Campanini N, Camisa R, Pucci F, Bui S, Ceccon G, Martinelli R, Fumagalli M, Losardo PL, Crafa P, Bordi C, Cascinu S, Ardizzoni A. Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. Br J Cancer 2008, 98(1):143-147. 10.1038/sj.bjc.6604131, 2359706, 18087284.
23. Zlobec I, Vuong T, Compton CC, Lugli A, Michel RP, Hayashi S, Jass JR. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy. Br J Cancer 2008, 98(2):450-456. 10.1038/sj.bjc.6604172, 2361457, 18182986.
24. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006, 56(1):37-47. quiz 50-31, 10.3322/canjclin.56.1.37, 16449185.
25. Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K. Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol 1997, 4(2):137-140. 10.1007/BF02303796, 9084850.
26. Li C, Oh SJ, Kim S, Hyung WJ, Yan M, Zhu ZG, Noh SH. Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size. J Gastrointest Surg 2009, 13(5):881-885. 10.1007/s11605-009-0800-3, 19184612.
27. Liu X, Xu Y, Long Z, Zhu H, Wang Y. Prognostic significance of tumor size in T3 gastric cancer. Ann Surg Oncol 2009, 16(7):1875-1882. 10.1245/s10434-009-0449-x, 19373514.
28. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Oro S, Tatebe S, Tsujitani S, Ikeguchi M. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg 2006, 192(3):296-300. 10.1016/j.amjsurg.2006.03.004, 16920421.
29. Wang X, Wan F, Pan J, Yu GZ, Chen Y, Wang JJ. Tumor size: a non-neglectable independent prognostic factor for gastric cancer. J Surg Oncol 2008, 97(3):236-240. 10.1002/jso.20951, 18095266.
30. Lugli A, Zlobec I, Singer G, Kopp Lugli A, Terracciano LM, Genta RM. Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiology. Nat Clin Pract Gastroenterol Hepatol 2007, 4(1):52-57. 10.1038/ncpgasthep0684, 17203089.
31. Engelen SM, Beets GL, Beets-Tan RG. Role of preoperative local and distant staging in rectal cancer. Onkologie 2007, 30(3):141-145. 10.1159/000099026, 17341902.
32. Karantanas AH, Yarmenitis S, Papanikolaou N, Gourtsoyiannis N. Preoperative imaging staging of rectal cancer. Dig Dis 2007, 25(1):20-32. 10.1159/000099167, 17384505.
33. Klessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol 2007, 17(2):379-389. 10.1007/s00330-006-0388-x, 1779628, 17008990.
34. Rao SX, Zeng MS, Xu JM, Qin XY, Chen CZ, Li RC, Hou YY. Assessment of T staging and mesorectal fascia status using high-resolution MRI in rectal cancer with rectal distention. World J Gastroenterol 2007, 13(30):4141-4146.
35. Lahaye MJ, Beets GL, Engelen SM, Kessels AG, de Bruine AP, Kwee HW, van Engelshoven JM, van de Velde CJ, Beets-Tan RG. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?. Radiology 2009, 252(1):81-91. 10.1148/radiol.2521081364, 19403848.
36. Muthusamy VR, Chang KJ. Optimal methods for staging rectal cancer. Clin Cancer Res 2007, 13(22 Pt 2):6877s-6884s. 10.1158/1078-0432.CCR-07-1137, 18006793.
37. Smith N, Brown G. Preoperative staging of rectal cancer. Acta Oncol 2008, 47(1):20-31. 10.1080/02841860701697720, 17957502.
38. Wolmark N, Fisher ER, Wieand HS, Fisher B. The relationship of depth of penetration and tumor size to the number of positive nodes in Dukes C colorectal cancer. Cancer 1984, 53(12):2707-2712. 10.1002/1097-0142(19840615)53:12<2707::AID-CNCR2820531225>3.0.CO;2-R, 6722730.
39. Cai G, Xu Y, Zhu X, Peng J, Li Z, Xiao C, Du X, Zhu J, Lian P, Sheng W, Guan Z, Cai S. A simple scoring system based on clinical features to predict locally advanced rectal cancers. J Gastrointest Surg 2009, 13(7):1299-1305. 10.1007/s11605-009-0892-9, 19367434.
40. Chok KS, Law WL. Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg 2007, 31(7):1485-1490. 10.1007/s00268-007-9089-0, 17510767.
41. Rasheed S, Bowley DM, Aziz O, Tekkis PP, Sadat AE, Guenther T, Boello ML, McDonald PJ, Talbot IC, Northover JM. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers. Colorectal Dis 2008, 10(3):231-238. 10.1111/j.1463-1318.2007.01411.x, 18257848.
42. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995, 38(12):1286-1295. 10.1007/BF02049154, 7497841.
43. Matsuda T, Saito Y, Fujii T, Uraoka T, Nakajima T, Kobayashi N, Emura F, Ono A, Shimoda T, Ikematsu H, Fu KI, Sano Y, Fujimori T. Size does not determine the grade of malignancy of early invasive colorectal cancer. World J Gastroenterol 2009, 15(22):2708-2713. 10.3748/wjg.15.2708, 2695885, 19522020.
44. Brodsky JT, Richard GK, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 1992, 69(2):322-326. 10.1002/1097-0142(19920115)69:2<322::AID-CNCR2820690208>3.0.CO;2-B, 1728363.
45. Choi PW, Yu CS, Jang SJ, Jung SH, Kim HC, Kim JC. Risk factors for lymph node metastasis in submucosal invasive colorectal cancer. World J Surg 2008, 32(9):2089-2094. 10.1007/s00268-008-9628-3, 18553050.
46. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002, 45(2):200-206. 10.1007/s10350-004-6147-7, 11852333.
47. Saclarides TJ, Bhattacharyya AK, Britton-Kuzel C, Szeluga D, Economou SG. Predicting lymph node metastases in rectal cancer. Dis Colon Rectum 1994, 37(1):52-57. 10.1007/BF02047215, 8287748.
48. Zhang H, Chen CS, Cong JC, Qiao L, Hasegawa T, Takashima S. Clinicopathological characteristics of advanced colorectal cancer 30 mm or smaller in diameter. Chin Med Sci J 2007, 22(2):98-103.